January 24, 2017 10:26 AM EST
Pharma

Ex-Mela chief Gul­fo joins the list of would-be FDA com­mish can­di­dates, col­or-cod­ed drug ap­proval plan in hand

John Carroll

Editor & Founder

A few weeks ago, Joseph Gul­fo spurred a con­sid­er­able round of chat­ter around a pro­pos­al for a col­or-cod­ed ap­proach to ap­prov­ing new drugs. Es­sen­tial­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

GSK ter­mi­nates Phase 2 tri­al of HBV ther­a­peu­tic vac­cine

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

Co­herus makes fi­nal, $483M piv­ot away from biosim­i­lars

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

A service from the Financial Times